A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
A phase 2 trial of DZD8586 and Venetoclax in chronic lymphocytic leukaemia, run by Dizal Pharmaceuticals, now recruiting.
Overview
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10) is a phase 2 interventional study registered as NCT07154264 by Dizal Pharmaceuticals, with 66 participants planned, started 2025-09-22 and due to reach its primary completion in 2029-12. Interventions recorded: DZD8586 and Venetoclax.
Similar pages
not linked directly; found by shared links- TrialDZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Shares DZD8586, Dizal Pharmaceutical, Chronic lymphocytic leukaemia and the tag pipeline.
- TrialA Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Shares DZD8586, Dizal Pharmaceutical, Chronic lymphocytic leukaemia.
- TrialA Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Shares Venetoclax, Chronic lymphocytic leukaemia and the tag pipeline.
- TrialA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period
Shares Venetoclax, Chronic lymphocytic leukaemia and the tag pipeline.
- TrialA Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
Shares Dizal Pharmaceutical and the tag pipeline.
- TrialStudy to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Shares Venetoclax, Chronic lymphocytic leukaemia and the tag pipeline.
- TrialA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Shares Venetoclax, Chronic lymphocytic leukaemia and the tag pipeline.
- TrialA Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Shares Venetoclax, Chronic lymphocytic leukaemia and the tag pipeline.